NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62 | +342.9% | 238,133 | +264.5% | 0.00% | – |
| Q4 2022 | $14 | -99.8% | 65,333 | +152.9% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 25,833 | +104.5% | 0.00% | – |
| Q2 2022 | $9,000 | -96.6% | 12,633 | -90.4% | 0.00% | – |
| Q1 2021 | $266,000 | +121.7% | 131,618 | +136.3% | 0.00% | – |
| Q4 2020 | $120,000 | -53.8% | 55,695 | -42.1% | 0.00% | – |
| Q3 2020 | $260,000 | -73.5% | 96,148 | -61.4% | 0.00% | -100.0% |
| Q2 2020 | $981,000 | – | 249,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |